IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,465,001 | +6.2% | 2,300,000 | +64.3% | 0.81% | +14.8% |
| Q2 2023 | $9,856,000 | +21.7% | 1,400,000 | +5.7% | 0.71% | +17.4% |
| Q1 2023 | $8,095,750 | +26.7% | 1,325,000 | +32.5% | 0.60% | +11.5% |
| Q4 2022 | $6,390,000 | -60.9% | 1,000,000 | -41.3% | 0.54% | -57.1% |
| Q3 2022 | $16,334,000 | -26.0% | 1,705,000 | -14.8% | 1.26% | -19.1% |
| Q2 2022 | $22,080,000 | -11.6% | 2,000,000 | +33.3% | 1.56% | +16.6% |
| Q1 2022 | $24,975,000 | +81.7% | 1,500,000 | +108.3% | 1.34% | +164.2% |
| Q4 2021 | $13,745,000 | -41.3% | 720,000 | -24.2% | 0.51% | -44.6% |
| Q3 2021 | $23,423,000 | -12.2% | 949,829 | -7.3% | 0.91% | -0.8% |
| Q2 2021 | $26,666,000 | +474.7% | 1,024,829 | +924.8% | 0.92% | +320.5% |
| Q4 2020 | $4,640,000 | +40.9% | 100,000 | 0.0% | 0.22% | -9.1% |
| Q3 2020 | $3,292,000 | +19.9% | 100,000 | 0.0% | 0.24% | +9.5% |
| Q2 2020 | $2,745,000 | -54.1% | 100,000 | -50.0% | 0.22% | -37.5% |
| Q1 2020 | $5,986,000 | +33.6% | 200,000 | -42.9% | 0.35% | +16.2% |
| Q2 2018 | $4,480,000 | -24.3% | 350,000 | 0.0% | 0.30% | -42.1% |
| Q1 2018 | $5,915,000 | +146.5% | 350,000 | +16.7% | 0.52% | +158.9% |
| Q4 2017 | $2,400,000 | +3.2% | 300,000 | 0.0% | 0.20% | -17.2% |
| Q3 2017 | $2,325,000 | – | 300,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |